About Likvor
Likvor is a company based in Umea (Sweden) founded in 2007. Likvor has raised $2.5 million across 6 funding rounds from investors including CareDx, Norrlandsfonden and BiotechUmea. Likvor operates in a competitive market with competitors including Luciole Medical, CND Life Sciences, PD Neurotechnology, NeuroKaire and Manus Neuro, among others.
- Headquarter Umea, Sweden
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.5 M (USD)
in 6 rounds
-
Latest Funding Round
Not available
-
Investors
CareDx
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Likvor
Unlock access to complete
Unlock access to complete
Funding Insights of Likvor
Likvor has successfully raised a total of $2.5M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Likvor
Likvor has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include CareDx, Norrlandsfonden and BiotechUmea.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A state-owned venture capital company focused on sustainable investments is operated.
|
Locked | Locked | Locked | |
|
Venture capital investments are made in northern Swedish growth companies.
|
Locked | Locked | Locked | |
|
Office supplies and equipment are offered by BiotechUmea.
|
Locked | Locked | Locked |
Investor details for Likvor
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Likvor
Investment portfolio details for Likvor
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Likvor
Detailed financials for Likvor
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Likvor Comparisons
Peer comparison for Likvor
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Likvor
Likvor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Luciole Medical, CND Life Sciences, PD Neurotechnology, NeuroKaire and Manus Neuro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Brain monitoring devices and analytics platforms are developed and provided.
|
|
| Locked | Locked | Locked |
Provider of a neurological disease diagnostic tool for providers
|
|
| Locked | Locked | Locked |
A wearable device is developed to monitor Parkinson's movement disorders.
|
|
| Locked | Locked | Locked |
Platform offering personalized treatment for psychiatric and neurological conditions
|
|
| Locked | Locked | Locked |
Devices for neuromotor impairment biomarkers are provided.
|
|
| Locked | Locked | Locked |
Noninvasive device developed for CSF monitoring and hydrocephalus management.
|
Detailed competitors of Likvor
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Likvor
Complete news archive for Likvor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Likvor
Likvor was founded in 2007.
Likvor is headquartered in Umea, Sweden.
Maria Wallin Wallberg is the current CEO of Likvor.
Likvor is a funded company, having raised a total of $2.5M across 6 funding rounds to date.
Founded in 2007 in Umea, Sweden, Likvor operates in the medical device sector focused on neurological diagnostics. The CELDA System has been developed to assess cerebrospinal fluid dynamics, incorporating an instrument, software, tools, and a specialized bed. Standardized results are provided for clinical investigations, supporting healthcare professionals in evaluating the CSF system. Operations emphasize precision and reliability in neurological procedures.
Likvor's top competitors include CND Life Sciences, NeuroKaire and Seer.
Likvor has 7 investors. Key investors include CareDx, Norrlandsfonden, BiotechUmea, Saminvest, and Partnerinvest Norr.